| Banner MD Anderson Cancer Center (BMDACC) is actively recruiting for a Division Chief of Pathology to lead cancer pathology services across the enterprise. BMDACC seeks an exceptionally well-trained pathologist, with recognized academic and leadership skills. The candidate will provide oversight and systemwide development of pathology and clinical laboratory services on behalf of Banner MD Anderson Cancer Center (BMDACC) at all locations. This position requires clinical and research expertise in an area of cancer pathology. The primary objective is to oversee the provision of pathology and clinical laboratory services to patients with solid tumors, hematologic malignancies, and benign hematology conditions. Molecular pathology is an integral component. Serves as Pathology Department Chair for BMDACC at the Gateway Medical Center thereby assuming all responsibilities associated with that role. These services will be coordinated and integrated with the Division of Pathology at the MD Anderson Cancer Center in Houston. The candidate will, in collaboration and partnership with Laboratory Sciences of Arizona, a Banner Health subsidiary that provides the clinical laboratories for Banner Health, ensure that clinical laboratory activities for BMDACC patients are standardized and appropriately support the research-driven, multidisciplinary, patient-centered, clinical mission of BMDACC. Through expertise, the right candidate will optimize the standardized laboratory services for patients with solid tumors, hematologic malignancies, and benign hematology conditions. Banner Health, a Top 10 Health System for clinical performance according to Thomson Reuters, has teamed with the MD Anderson Cancer Center, ranked number one by U.S. News and World Report, to deliver exceptional, comprehensive cancer services across multiple locations. This program is the broadest extension of MD Anderson’s services outside of Houston and brings an unprecedented level of cancer care to the Phoenix and Northern Colorado Regions. BMDACC currently has 80 active clinical trials, over 400 patients accrued, and over 40 research staff. The program has numerous publications in the most respected medical journals, which include four recent publications in the New England Journal of Medicine. BMDACC saw over 7,000 new patients last year and had 152,000 total patient visits. The Center did 75 stem-cell transplants and was the first to perform CAR T-call therapy in Arizona. Today, in addition to the main Cancer Center at Banner Gateway Medical Center, the program provides services at six other Banner facilities, four in Arizona and two in Northern Colorado. |
